<p>中東股市近期出現了混合走勢，沙特股市因獲利回吐而下跌，而卡塔爾指數則小幅上漲，反映出地區經濟的持續變化。儘管它們給人一種復古的感覺，便士股票仍然是對那些對小型或新興公司感興趣的投資者來説一個相關的投資領域。這些股票在強勁的財務支持下，能夠提供可負擔性和潛在的增長，使其成為尋求低調機會的投資者的有趣選擇。</p>
<h3>中東地區十大便士股票</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>股價</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益與風險</strong></td>
</tr>
<tr>
<td>Maharah for Human Resources (SASE:1831)</td>
<td>SAR4.71</td>
<td>SAR2.11B</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Thob Al Aseel (SASE:4012)</td>
<td>SAR3.69</td>
<td>SAR1.48B</td>
<td>✅ 2 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Alarum Technologies (TASE:ALAR)</td>
<td>₪4.835</td>
<td>₪344.3M</td>
<td>✅ 3 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>E7 Group PJSC (ADX:E7)</td>
<td>AED1.04</td>
<td>AED2.1B</td>
<td>✅ 5 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Al Wathba National Insurance Company PJSC (ADX:AWNIC)</td>
<td>AED3.30</td>
<td>AED683.1M</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Dubai National Insurance &amp; Reinsurance (P.S.C.) (DFM:DNIR)</td>
<td>AED3.30</td>
<td>AED381.15M</td>
<td>✅ 2 ⚠️ 4 查看分析</td>
</tr>
<tr>
<td>Dubai Investments PJSC (DFM:DIC)</td>
<td>AED3.08</td>
<td>AED13.05B</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Al Dhafra Insurance Company P.S.C (ADX:DHAFRA)</td>
<td>AED4.86</td>
<td>AED486M</td>
<td>✅ 1 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC)</td>
<td>AED0.82</td>
<td>AED503.63M</td>
<td>✅ 2 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Tgi Infrastructures (TASE:TGI)</td>
<td>₪2.705</td>
<td>₪212.34M</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
</tbody>
</table>
<p>點擊這裏查看我們中東便士股票篩選器的 79 只股票的完整列表。</p>
<p>下面我們展示了一些經過篩選的股票。</p>
<h2>烏姆蓋萬國家銀行 (PSC) (ADX:NBQ)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> 烏姆蓋萬國家銀行 (PSC) 在阿聯酋提供零售和企業銀行服務，市值為 AED5.38 億。</p>
<p><strong>運營：</strong> 銀行的收入主要來自國庫和投資，貢獻 AED410.1 百萬，以及零售和企業銀行，增加 AED342.24 百萬。</p>
<p><strong>市值：</strong> AED5.38B</p>
<p>烏姆蓋萬國家銀行 (PSC) 以 AED5.38 億的穩健市值脱穎而出，主要得益於國庫和投資的可觀收入，以及零售和企業銀行。儘管每週波動率穩定在 5%，但該銀行的盈利增長在過去一年中減速至 0.3%，低於其五年平均水平 19.8%。該銀行的貸款與存款比率適中，為 63%，但面臨 2.2% 的高不良貸款挑戰。其市盈率為 10.1 倍，儘管股本回報率仍然較低，為 8.6%。</p>
<ul>
<li>點擊這裏瞭解烏姆蓋萬國家銀行 (PSC) 的細微差別，查看我們的詳細分析財務健康報告。</li>
<li>在這裏瞭解烏姆蓋萬國家銀行 (PSC) 的歷史表現。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b01d9b94-4ba6-4452-b10b-790b7e5998af/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b01d9b94-4ba6-4452-b10b-790b7e5998af/chart/financial-position-analysis"/></p>
<p>ADX:NBQ 財務狀況分析截至 2025 年 9 月</p>
<h2>InterCure (TASE:INCR)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> InterCure Ltd. 從事醫用大麻及大麻基產品的研究、種植、生產、營銷和分銷，業務覆蓋以色列及國際市場，市值為 ₪235.67 百萬。</p>
<p><strong>運營：</strong> 該公司的收入主要來自其大麻業務，貢獻 ₪238.85 百萬。</p>
<p><strong>市值：</strong> ₪235.67M</p>
<p>InterCure Ltd. 的市值為 ₪235.67 百萬，主要來自其大麻業務，總收入為 ₪238.85 百萬。儘管公司處於虧損狀態，股本回報率為負 18.3%，但其短期資產為 ₪391.8 百萬，超過其短期和長期負債，顯示出強勁的流動性。公司的債務與股本比率在五年內有所上升，但仍保持在 26.3% 的滿意水平。InterCure 的董事會經驗豐富，平均任期為七年；然而，由於缺乏任期長度的數據，管理團隊的經驗尚不明確。</p>
<ul>
<li>點擊這裏深入瞭解 InterCure 的具體情況，查看我們的詳細資產負債表健康報告。</li>
<li>通過我們的詳細歷史表現報告評估 InterCure 的過去業績。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/e639da53-20ca-43ad-bcf7-9318fe606b2c/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/e639da53-20ca-43ad-bcf7-9318fe606b2c/chart/debt-equity-history-analysis"/></p>
<p>TASE:INCR 債務與股本歷史及分析截至 2025 年 9 月</p>
<h2>SavorEat (TASE:SVRT-M)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> SavorEat Ltd. 是一家開發基於纖維素的肉類替代品的公司，旨在模擬真實肉類的食用體驗，市值為 ₪5.35 百萬。</p>
<p><strong>運營：</strong> SavorEat Ltd. 尚未報告任何收入細分。</p>
<p><strong>市值：</strong> ₪5.35M</p>
<p>SavorEat Ltd. 的市值為 ₪5.35 百萬，仍處於無收入和虧損狀態，2025 年上半年報告淨虧損 ILS 4.92 百萬。儘管沒有債務且董事會經驗豐富，平均任期為 5.6 年，但由於其股價高度波動以及基於當前自由現金流趨勢的現金流不足一年，公司面臨財務挑戰。短期資產（₪6.2M）超過負債（₪840K），提供了一定的流動性緩衝，但盈利能力仍然難以實現，五年來虧損年均增長 2.5%。</p>
<ul>
<li>點擊這裏訪問我們的完整財務健康分析報告，以瞭解 SavorEat 的動態。</li>
<li>通過查看我們的歷史表現報告，獲取 SavorEat 的歷史結果的見解。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/035f9675-2f76-4849-93b9-566b1416b415/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/035f9675-2f76-4849-93b9-566b1416b415/chart/financial-position-analysis"/></p>
<p>截至 2025 年 9 月的 TASE:SVRT-M 財務狀況分析</p>
<h2>將想法轉化為行動</h2>
<ul>
<li>點擊這裏訪問我們 79 只中東便士股票的完整索引。</li>
<li>對其他選擇感到好奇？人工智能即將改變醫療保健。這 31 只股票正在從早期診斷到藥物發現的各個方面進行研發。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前投資。</li>
</ul>
<p><em>這篇文章由 Simply Wall St 撰寫，內容具有一般性。<strong>我們提供基於歷史數據和分析師預測的評論，採用無偏見的方法，我們的文章並不構成財務建議。</strong> 它不構成買入或賣出任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>

INCR

ALAR

<p>中東股市正經歷混合走勢，沙特因獲利了結而出現下跌，而卡塔爾的指數則上漲。被忽視的低價股提供了負擔得起的投資機會，具有潛在的增長空間。值得關注的股票包括 Maharah 人力資源公司、Thob Al Aseel 和 Alarum Technologies 等。烏姆阿爾凱温國家銀行顯示出穩健的市值，但面臨不良貸款的挑戰。InterCure 在大麻行業運營，但尚未盈利，而專注於肉類替代品的 SavorEat 則處於無收入狀態，並面臨財務困難。投資者被鼓勵探索這些不被關注的投資選項</p>

<p>The Middle Eastern stock markets have recently experienced mixed movements, with the Saudi bourse seeing losses due to profit-taking while Qatar's index has edged higher, reflecting ongoing regional economic shifts. Despite their vintage feel, penny stocks remain a relevant investment area for those interested in smaller or newer companies. These stocks can offer affordability and potential growth when backed by strong financials, making them intriguing options for investors seeking under-the-radar opportunities.</p>
<div class="lb-trans"><p>中東股市近期出現了混合走勢，沙特股市因獲利回吐而下跌，而卡塔爾指數則小幅上漲，反映出地區經濟的持續變化。儘管它們給人一種復古的感覺，便士股票仍然是對那些對小型或新興公司感興趣的投資者來説一個相關的投資領域。這些股票在強勁的財務支持下，能夠提供可負擔性和潛在的增長，使其成為尋求低調機會的投資者的有趣選擇。</p>
</div><h3>Top 10 Penny Stocks In The Middle East</h3>
<div class="lb-trans"><h3>中東地區十大便士股票</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Share Price</strong></td>
<td><strong>Market Cap</strong></td>
<td><strong>Rewards &amp; Risks</strong></td>
</tr>
<tr>
<td>Maharah for Human Resources (SASE:1831)</td>
<td>SAR4.71</td>
<td>SAR2.11B</td>
<td>✅ 2 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Thob Al Aseel (SASE:4012)</td>
<td>SAR3.69</td>
<td>SAR1.48B</td>
<td>✅ 2 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Alarum Technologies (TASE:ALAR)</td>
<td>₪4.835</td>
<td>₪344.3M</td>
<td>✅ 3 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>E7 Group PJSC (ADX:E7)</td>
<td>AED1.04</td>
<td>AED2.1B</td>
<td>✅ 5 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Al Wathba National Insurance Company PJSC (ADX:AWNIC)</td>
<td>AED3.30</td>
<td>AED683.1M</td>
<td>✅ 2 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Dubai National Insurance &amp; Reinsurance (P.S.C.) (DFM:DNIR)</td>
<td>AED3.30</td>
<td>AED381.15M</td>
<td>✅ 2 ⚠️ 4 View Analysis &gt;</td>
</tr>
<tr>
<td>Dubai Investments PJSC (DFM:DIC)</td>
<td>AED3.08</td>
<td>AED13.05B</td>
<td>✅ 2 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Al Dhafra Insurance Company P.S.C (ADX:DHAFRA)</td>
<td>AED4.86</td>
<td>AED486M</td>
<td>✅ 1 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC)</td>
<td>AED0.82</td>
<td>AED503.63M</td>
<td>✅ 2 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Tgi Infrastructures (TASE:TGI)</td>
<td>₪2.705</td>
<td>₪212.34M</td>
<td>✅ 2 ⚠️ 3 View Analysis &gt;</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>股價</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益與風險</strong></td>
</tr>
<tr>
<td>Maharah for Human Resources (SASE:1831)</td>
<td>SAR4.71</td>
<td>SAR2.11B</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Thob Al Aseel (SASE:4012)</td>
<td>SAR3.69</td>
<td>SAR1.48B</td>
<td>✅ 2 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Alarum Technologies (TASE:ALAR)</td>
<td>₪4.835</td>
<td>₪344.3M</td>
<td>✅ 3 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>E7 Group PJSC (ADX:E7)</td>
<td>AED1.04</td>
<td>AED2.1B</td>
<td>✅ 5 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Al Wathba National Insurance Company PJSC (ADX:AWNIC)</td>
<td>AED3.30</td>
<td>AED683.1M</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Dubai National Insurance &amp; Reinsurance (P.S.C.) (DFM:DNIR)</td>
<td>AED3.30</td>
<td>AED381.15M</td>
<td>✅ 2 ⚠️ 4 查看分析</td>
</tr>
<tr>
<td>Dubai Investments PJSC (DFM:DIC)</td>
<td>AED3.08</td>
<td>AED13.05B</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Al Dhafra Insurance Company P.S.C (ADX:DHAFRA)</td>
<td>AED4.86</td>
<td>AED486M</td>
<td>✅ 1 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC)</td>
<td>AED0.82</td>
<td>AED503.63M</td>
<td>✅ 2 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Tgi Infrastructures (TASE:TGI)</td>
<td>₪2.705</td>
<td>₪212.34M</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 79 stocks from our Middle Eastern Penny Stocks screener.</p>
<div class="lb-trans"><p>點擊這裏查看我們中東便士股票篩選器的 79 只股票的完整列表。</p>
</div><p>Underneath we present a selection of stocks filtered out by our screen.</p>
<div class="lb-trans"><p>下面我們展示了一些經過篩選的股票。</p>
</div><h2>National Bank of Umm Al-Qaiwain (PSC) (ADX:NBQ)</h2>
<div class="lb-trans"><h2>烏姆蓋萬國家銀行 (PSC) (ADX:NBQ)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> National Bank of Umm Al-Qaiwain (PSC) provides retail and corporate banking services in the United Arab Emirates, with a market capitalization of AED5.38 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 烏姆蓋萬國家銀行 (PSC) 在阿聯酋提供零售和企業銀行服務，市值為 AED5.38 億。</p>
</div><p><strong>Operations:</strong> The bank's revenue is primarily derived from Treasury and Investments, contributing AED410.1 million, and Retail and Corporate Banking, which adds AED342.24 million.</p>
<div class="lb-trans"><p><strong>運營：</strong> 銀行的收入主要來自國庫和投資，貢獻 AED410.1 百萬，以及零售和企業銀行，增加 AED342.24 百萬。</p>
</div><p><strong>Market Cap:</strong> AED5.38B</p>
<div class="lb-trans"><p><strong>市值：</strong> AED5.38B</p>
</div><p>National Bank of Umm Al-Qaiwain (PSC) stands out with a solid market capitalization of AED5.38 billion, driven by substantial revenue from Treasury and Investments, as well as Retail and Corporate Banking. Despite a stable weekly volatility at 5%, the bank's earnings growth has decelerated to 0.3% over the past year, trailing behind its five-year average of 19.8%. The bank maintains an appropriate Loans to Deposits ratio at 63% but faces challenges with high bad loans at 2.2%. Its Price-To-Earnings ratio is competitive at 10.1x, though Return on Equity remains low at 8.6%.</p>
<div class="lb-trans"><p>烏姆蓋萬國家銀行 (PSC) 以 AED5.38 億的穩健市值脱穎而出，主要得益於國庫和投資的可觀收入，以及零售和企業銀行。儘管每週波動率穩定在 5%，但該銀行的盈利增長在過去一年中減速至 0.3%，低於其五年平均水平 19.8%。該銀行的貸款與存款比率適中，為 63%，但面臨 2.2% 的高不良貸款挑戰。其市盈率為 10.1 倍，儘管股本回報率仍然較低，為 8.6%。</p>
</div><ul>
<li>Click here to discover the nuances of National Bank of Umm Al-Qaiwain (PSC) with our detailed analytical financial health report.</li>
<li>Learn about National Bank of Umm Al-Qaiwain (PSC)'s historical performance here.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏瞭解烏姆蓋萬國家銀行 (PSC) 的細微差別，查看我們的詳細分析財務健康報告。</li>
<li>在這裏瞭解烏姆蓋萬國家銀行 (PSC) 的歷史表現。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b01d9b94-4ba6-4452-b10b-790b7e5998af/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/b01d9b94-4ba6-4452-b10b-790b7e5998af/chart/financial-position-analysis"/></p>
<p>ADX:NBQ Financial Position Analysis as at Sep 2025</p>
<div class="lb-trans"><p>ADX:NBQ 財務狀況分析截至 2025 年 9 月</p>
</div><h2>InterCure (TASE:INCR)</h2>
<div class="lb-trans"><h2>InterCure (TASE:INCR)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> InterCure Ltd. operates in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use both in Israel and internationally, with a market cap of ₪235.67 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> InterCure Ltd. 從事醫用大麻及大麻基產品的研究、種植、生產、營銷和分銷，業務覆蓋以色列及國際市場，市值為 ₪235.67 百萬。</p>
</div><p><strong>Operations:</strong> The company generates revenue primarily from its cannabis segment, which accounted for ₪238.85 million.</p>
<div class="lb-trans"><p><strong>運營：</strong> 該公司的收入主要來自其大麻業務，貢獻 ₪238.85 百萬。</p>
</div><p><strong>Market Cap:</strong> ₪235.67M</p>
<div class="lb-trans"><p><strong>市值：</strong> ₪235.67M</p>
</div><p>InterCure Ltd., with a market cap of ₪235.67 million, primarily generates revenue from its cannabis segment, totaling ₪238.85 million. Despite being unprofitable with a negative Return on Equity of -18.3%, the company maintains short-term assets of ₪391.8 million that exceed both its short and long-term liabilities, indicating a strong liquidity position. The company's debt to equity ratio has increased over five years but remains satisfactory at 26.3%. InterCure's board is experienced with an average tenure of seven years; however, the management team's experience is unclear due to insufficient data on tenure lengths.</p>
<div class="lb-trans"><p>InterCure Ltd. 的市值為 ₪235.67 百萬，主要來自其大麻業務，總收入為 ₪238.85 百萬。儘管公司處於虧損狀態，股本回報率為負 18.3%，但其短期資產為 ₪391.8 百萬，超過其短期和長期負債，顯示出強勁的流動性。公司的債務與股本比率在五年內有所上升，但仍保持在 26.3% 的滿意水平。InterCure 的董事會經驗豐富，平均任期為七年；然而，由於缺乏任期長度的數據，管理團隊的經驗尚不明確。</p>
</div><ul>
<li>Dive into the specifics of InterCure here with our thorough balance sheet health report.</li>
<li>Assess InterCure's previous results with our detailed historical performance reports.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏深入瞭解 InterCure 的具體情況，查看我們的詳細資產負債表健康報告。</li>
<li>通過我們的詳細歷史表現報告評估 InterCure 的過去業績。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/e639da53-20ca-43ad-bcf7-9318fe606b2c/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/e639da53-20ca-43ad-bcf7-9318fe606b2c/chart/debt-equity-history-analysis"/></p>
<p>TASE:INCR Debt to Equity History and Analysis as at Sep 2025</p>
<div class="lb-trans"><p>TASE:INCR 債務與股本歷史及分析截至 2025 年 9 月</p>
</div><h2>SavorEat (TASE:SVRT-M)</h2>
<div class="lb-trans"><h2>SavorEat (TASE:SVRT-M)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> SavorEat Ltd. is a company that develops cellulose-based meat substitutes designed to mimic the eating experience of real meat, with a market cap of ₪5.35 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> SavorEat Ltd. 是一家開發基於纖維素的肉類替代品的公司，旨在模擬真實肉類的食用體驗，市值為 ₪5.35 百萬。</p>
</div><p><strong>Operations:</strong> No revenue segments have been reported for SavorEat Ltd.</p>
<div class="lb-trans"><p><strong>運營：</strong> SavorEat Ltd. 尚未報告任何收入細分。</p>
</div><p><strong>Market Cap:</strong> ₪5.35M</p>
<div class="lb-trans"><p><strong>市值：</strong> ₪5.35M</p>
</div><p>SavorEat Ltd., with a market cap of ₪5.35 million, remains pre-revenue and unprofitable, reporting a net loss of ILS 4.92 million for the first half of 2025. Despite having no debt and an experienced board with an average tenure of 5.6 years, the company faces financial challenges due to its highly volatile share price and less than one year of cash runway based on current free cash flow trends. Short-term assets (₪6.2M) exceed liabilities (₪840K), providing some liquidity cushion, though profitability remains elusive as losses have increased by 2.5% annually over five years.</p>
<div class="lb-trans"><p>SavorEat Ltd. 的市值為 ₪5.35 百萬，仍處於無收入和虧損狀態，2025 年上半年報告淨虧損 ILS 4.92 百萬。儘管沒有債務且董事會經驗豐富，平均任期為 5.6 年，但由於其股價高度波動以及基於當前自由現金流趨勢的現金流不足一年，公司面臨財務挑戰。短期資產（₪6.2M）超過負債（₪840K），提供了一定的流動性緩衝，但盈利能力仍然難以實現，五年來虧損年均增長 2.5%。</p>
</div><ul>
<li>Click here and access our complete financial health analysis report to understand the dynamics of SavorEat.</li>
<li>Gain insights into SavorEat's historical outcomes by reviewing our past performance report.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏訪問我們的完整財務健康分析報告，以瞭解 SavorEat 的動態。</li>
<li>通過查看我們的歷史表現報告，獲取 SavorEat 的歷史結果的見解。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/035f9675-2f76-4849-93b9-566b1416b415/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/035f9675-2f76-4849-93b9-566b1416b415/chart/financial-position-analysis"/></p>
<p>TASE:SVRT-M Financial Position Analysis as at Sep 2025</p>
<div class="lb-trans"><p>截至 2025 年 9 月的 TASE:SVRT-M 財務狀況分析</p>
</div><h2>Turning Ideas Into Actions</h2>
<div class="lb-trans"><h2>將想法轉化為行動</h2>
</div><ul>
<li>Click here to access our complete index of 79 Middle Eastern Penny Stocks.</li>
<li>Curious About Other Options? AI is about to change healthcare. These 31 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏訪問我們 79 只中東便士股票的完整索引。</li>
<li>對其他選擇感到好奇？人工智能即將改變醫療保健。這 31 只股票正在從早期診斷到藥物發現的各個方面進行研發。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前投資。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>這篇文章由 Simply Wall St 撰寫，內容具有一般性。<strong>我們提供基於歷史數據和分析師預測的評論，採用無偏見的方法，我們的文章並不構成財務建議。</strong> 它不構成買入或賣出任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>
</div>

市值超過 100 萬美元的中東低價股